# Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)

> **NCT00274027** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 19 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** tiotropium bromide

## Key facts

- **NCT ID:** NCT00274027
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2003-03
- **Final completion:** 2003-03
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00274027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00274027, "Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00274027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*